PRIMARY STUDY
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis
Key Findings: This report identifies a compound that inhibits FAAH activity and reduces bowel inflammation.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): France
Year of Pub: 2011
Cannabinoids Studied: Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
